ARAV insider filings
Aravive, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-04-11. Screen ARAV transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ARAV between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Aravive, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-04-11 | 4 | Petrini Maria Carolina — Chief Commercial Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Geller Robert B. — Chief Medical Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Dove Leonard Scott — Chief Operating Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | McIntyre Gail Frances — CEO and President, Director | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | HOWARD RUDY — Chief Financial Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2022-10-27 | 4/A | Ho Peter Tai-Ching — Director | Grant/award (A): 54,353 @ $0.92 · Grant/award (A): 27,177 (derivative) · Grant/award (A): 27,176 (derivative) | EDGAR |
| 2022-10-27 | 4/A | Zhang Eric — Director | Grant/award (A): 543,537 @ $0.92 · Grant/award (A): 271,769 (derivative) · Grant/award (A): 271,768 (derivative) | EDGAR |
| 2022-10-26 | 4 | Giaccia Amato — Director | Grant/award (A): 271,768 @ $0.92 · Grant/award (A): 135,884 (derivative) · Grant/award (A): 135,884 (derivative) | EDGAR |
| 2022-10-26 | 4 | Zhang Eric — Director | Grant/award (A): 543,537 @ $0.92 · Grant/award (A): 271,769 (derivative) · Grant/award (A): 271,768 (derivative) | EDGAR |
| 2022-10-26 | 4 | Ho Peter Tai-Ching — Director | Grant/award (A): 54,353 @ $0.92 · Grant/award (A): 27,177 (derivative) · Grant/award (A): 27,176 (derivative) | EDGAR |
| 2022-10-26 | 4 | McIntyre Gail Frances — CEO and President, Director | Grant/award (A): 54,353 @ $0.92 · Grant/award (A): 27,177 (derivative) · Grant/award (A): 27,176 (derivative) | EDGAR |
| 2022-10-26 | 4 | HOWARD RUDY — Chief Financial Officer | Grant/award (A): 10,870 @ $0.92 · Grant/award (A): 5,435 (derivative) · Grant/award (A): 5,435 (derivative) | EDGAR |
| 2022-10-26 | 4 | ESHELMAN FREDRIC N — Executive Chairman, Director, 10% owner Eshelman Ventures, LLC — Director, 10% owner | Grant/award (A): 16,306,120 @ $0.92 · Grant/award (A): 8,153,060 (derivative) · Grant/award (A): 8,153,060 (derivative) | EDGAR |
| 2022-09-26 | 4 | Zhang Eric — Director | Grant/award (A): 97,063 (derivative) @ $0 | EDGAR |
| 2022-09-26 | 4 | Giaccia Amato — Director | Grant/award (A): 97,063 (derivative) @ $0 | EDGAR |
| 2022-09-26 | 4 | Ho Peter Tai-Ching — Director | Grant/award (A): 97,063 (derivative) @ $0 | EDGAR |
| 2022-09-26 | 4 | Hohneker John — Director | Grant/award (A): 97,063 (derivative) @ $0 | EDGAR |
| 2022-09-26 | 4 | Kirk Sigurd — Director | Grant/award (A): 97,063 (derivative) @ $0 | EDGAR |
| 2022-09-26 | 4 | ROGERS MICHAEL W — Director | Grant/award (A): 97,063 (derivative) @ $0 | EDGAR |
| 2022-09-26 | 4 | ESHELMAN FREDRIC N — Executive Chairman, Director, 10% owner Eshelman Ventures, LLC — Director, 10% owner | Grant/award (A): 97,063 (derivative) @ $0 | EDGAR |
| 2022-07-05 | 4 | Geller Robert B. — Chief Medical Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | HOWARD RUDY — Chief Financial Officer | Grant/award (A): 290,000 (derivative) @ $0 | EDGAR |
| 2022-04-04 | 4 | ESHELMAN FREDRIC N — Executive Chairman of Board, Director, 10% owner Eshelman Ventures, LLC — 10% owner | Option exercise (M): 4,545,455 @ $0.00 · Option exercise (M): 4,545,455 (derivative) @ $0 | EDGAR |
| 2022-03-31 | 4 | ESHELMAN FREDRIC N — Executive Chairman of Board, Director, 10% owner Eshelman Ventures, LLC — Director, 10% owner | Grant/award (A): 860,216 @ $2.33 · Grant/award (A): 860,216 (derivative) @ $2.20 | EDGAR |
| 2022-03-22 | 4 | Dove Leonard Scott — Chief Operating Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2022-01-25 | 4 | Shah Vinay — Chief Financial Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2022-01-25 | 4 | Rangwala Reshma — Chief Medical Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2022-01-25 | 4 | McIntyre Gail Frances — CEO and President, Director | Grant/award (A): 425,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | ESHELMAN FREDRIC N — Executive Chairman of Board, Director, 10% owner Eshelman Ventures, LLC — Director, 10% owner | Grant/award (A): 4,545,455 (derivative) @ $2.20 | EDGAR |
| 2021-12-23 | 4 | Giaccia Amato — Director | Gift (G): 48,366 @ $0 | EDGAR |
| 2021-12-02 | 4 | Giaccia Amato — Director | Option exercise (M): 12,350 @ $0.06 · Option exercise (M): 38,761 @ $0.24 · Option exercise (M): 500 @ $0.24 · Sale (S): 252 @ $3.22 · Sale (S): 2,954 @ $3.22 · Sale (S): 39 @ $3.22 · +3 more | EDGAR |
| 2021-09-13 | 4 | Giaccia Amato — Director | Grant/award (A): 22,812 (derivative) @ $0 | EDGAR |
| 2021-09-13 | 4 | Zhang Eric — Director | Grant/award (A): 22,812 (derivative) @ $0 | EDGAR |
| 2021-09-13 | 4 | Hohneker John — Director | Grant/award (A): 22,812 (derivative) @ $0 | EDGAR |
| 2021-09-13 | 4 | Ho Peter Tai-Ching — Director | Grant/award (A): 22,812 (derivative) @ $0 | EDGAR |
| 2021-09-13 | 4 | Kirk Sigurd — Director | Grant/award (A): 22,812 (derivative) @ $0 | EDGAR |
| 2021-09-13 | 4 | ROGERS MICHAEL W — Director | Grant/award (A): 22,812 (derivative) @ $0 | EDGAR |
| 2021-09-13 | 4 | ESHELMAN FREDRIC N — Director, 10% owner Eshelman Ventures, LLC — Director, 10% owner | Grant/award (A): 22,812 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Ho Peter Tai-Ching — Director | Grant/award (A): 15,435 (derivative) @ $0 · Grant/award (A): 5,245 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Hohneker John — Director | Grant/award (A): 15,435 (derivative) @ $0 · Grant/award (A): 5,245 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Kirk Sigurd — Director | Grant/award (A): 15,435 (derivative) @ $0 · Grant/award (A): 5,245 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Shah Vinay — Chief Financial Officer | Purchase (P): 1,000 @ $5.31 | EDGAR |
| 2021-06-29 | 4 | McIntyre Gail Frances — CEO and President, Director | Purchase (P): 1,000 @ $5.34 | EDGAR |
| 2021-03-22 | 4 | Giaccia Amato — Director | Option exercise (M): 8,055 @ $0.06 · Option exercise (M): 4,028 @ $0.06 · Gift (G): 12,083 @ $0 · Option exercise (M): 8,055 (derivative) @ $0 · Option exercise (M): 4,028 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | ESHELMAN FREDRIC N — Director, 10% owner Eshelman Ventures, LLC — 10% owner | Grant/award (A): 2,875,000 @ $7.29 | EDGAR |
| 2021-01-26 | 4 | Rangwala Reshma — Chief Medical Officer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-26 | 4 | Shah Vinay — Chief Financial Officer | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2021-01-26 | 4 | McIntyre Gail Frances — CEO and President, Director | Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2020-12-07 | 4 | Shah Vinay — Chief Financial Officer | Purchase (P): 8,000 @ $5.76 | EDGAR |
| 2020-12-07 | 4 | McIntyre Gail Frances — CEO and President, Director | Purchase (P): 8,000 @ $5.77 | EDGAR |
Recent 8-K events — Aravive, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-01-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-03 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-19 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-02 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-25 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-04-11 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ARAV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs